Lye DC, Archuleta S, Syed-Omar SF, Low JG, Oh HM, Wei Y, et al.
Lancet. 2017 Apr 22;389(10079):1611-1618. Epub 2017 Mar 8.
PMID: 28283286 Clinical Trial.
Lye DC, Archuleta S, Syed-Omar SF, Low JG, Oh HM, Wei Y, et al.
Lancet. 2017 Apr 22;389(10079):1611-1618. Epub 2017 Mar 8.
PMID: 28283286 Clinical Trial.
Protocol
Background:
Blood transfusions are currently one of the most performed medical procedures in the world. However, the medical literature shows a relationship between the use of allogeneic (donated) blood and greater complications, including, greater mortality. Worldwide, there is a deficiency in medical knowledge about transfusion practice.
Objectives:
1. To change the current transfusion practice, through the application of scientifically safe and effective PROTOCOLS for the TREATMENT OF ANEMIA and MANAGEMENT OF BLEEDING without the use of allogeneic blood, based on the scientific evidence of modern medicine.
2. Help blood banks SAVE their main HEMOCOMPONENTS (red blood cells, plasma and platelets)